Gov. Josh Shapiro, in his first 100 days in Pennsylvania's top job, visited the PABC on April 27 with Rick Siger, acting secretary of the Department of Community and Economic Development. Five days later he shared on social media a positive review of our operation. Please watch it here. His office's news release is here.
Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) was chosen by the Philadelphia Business Journal for its Power 101 list, which is being released this week. Kassa became named CEO of the organizations on July 1, succeeding co-founder Timothy M. Block, PhD. In 2019, Dr. Block was named by the Philadelphia Business Journal to its Power 100 list. Please read more here.
State legislators joined the CEOs of the nonprofit Pennsylvania Biotechnology Center (PABC) and Brandywine Realty Trust to announce today that the Commonwealth of Pennsylvania is making a $5 million investment in the PABC’s new Academic Innovation Zone program. Ranked as one of the nation’s most successful life sciences incubators, the PABC operates two facilities. The headquarters and original location is in Doylestown, and B+labs at Cira Center is in Philadelphia. B+labs is run by the PABC in partnership with Brandywine Realty Trust. Please read more here.
Brandywine Realty Trust (NYSE: BDN) and Pennsylvania Biotechnology Center (PABC) announce B+labs at Cira Centre is not only open but fully leased. The list of life science leaders occupying the B+labs community includes 3D Systems, Asklepios Biopharmaceutical (AskBio), BriaCell Therapeutics Corp., Carisma Therapeutics, Ceptur Therapeutics, Quanta Therapeutics, Synapticure, Tmunity Therapeutics, Vetigenics, and Vitara Biomedical, among others. Please read more here.
Louis P. Kassa III, MPA, became president of the nonprofit Pennsylvania Biotechnology Center (PABC) on July 1, 2022. He also is now chief executive officer of the PABC, Hepatitis B Foundation and Baruch S. Blumberg Institute. Kassa, who joined the organizations in 2014, succeeded Timothy M. Block, PhD, founding president of the PABC. Dr. Block has become executive chair of the Hepatitis B Foundation Board of Directors, which governs the PABC and Blumberg Institute. Please read more here.
The nonprofit Pennsylvania Biotechnology Center (PABC), one of the nation’s most successful life sciences incubators, generated $7.3 billion in economic activity in the region during 2016 to 2021, according to a new study commissioned by the PABC’s management. During those six years, the Doylestown-area biotech facility produced 1,135 new jobs. Of those, 500 were jobs with PABC-member companies and 635 were jobs in Pennsylvania, excluding Bucks County. Please read more here.
The Pennsylvania Biotechnology Center (PABC) generated $7.3 billion in economic activity in the region during 2016 to 2021, according to a new study commissioned by the PABC’s management. Please read more here.
The nonprofit Pennsylvania Biotechnology Center (PABC), one of the nation’s most successful life sciences incubators, is proud to announce that IGM Biosciences Inc. (Nasdaq: IGMS) of Mountain View, Calif., is one of the center’s newest member companies and will be expanding its R&D footprint at the PABC’s Doylestown campus. Please read more here.
State Senator Steve Santarsiero (D-10) announced today that he has secured $1,577,500 in state funds from the Redevelopment Assistance Capital Program (RACP) for the Pennsylvania Biotechnology Center, the life sciences incubator in Buckingham Township. “I’d like to thank Governor Wolf for supporting my request to dedicate RACP funds for the continued growth and expansion of the Pennsylvania Biotechnology Center,” said Sen. Santarsiero. Please read more here.
Doylestown, Nov. 19, 2020 – Louis P. Kassa, MPA, executive vice president and chief operating officer of the Pennsylvania Biotechnology Center, has been named one of “The 10 Best COOs of 2020” by Industry Era, a global technology media outlet. The list includes COOs from a wide variety of organizations worldwide.
Since joining the Pennsylvania Biotechnology Center (PABC) in 2014, Kassa has led the PABC to become one of the nation’s leading life sciences incubators, according to a report by the International Business Innovation Association.
The PABC is a nonprofit that offers state-of-the-art laboratory and office space to early stage biotech companies, as well as the Hepatitis B Foundation and Blumberg Institute. With more than 70 member companies, the center is home to 41 small to mid-size science, research and biotechnology companies. The PABC has been at full capacity for the past seven years and there is a waiting list of companies that want to locate in the PABC, Kassa said. “We have a very specific ecosystem and services platform that helps entrepreneurs find a path for success,” Kassa said.
Learn More 
